Contact this trialFirst, we need to learn more about you.
Device
Lixelle® for Dialysis Amyloidosis
Recruiting1 award5 criteria
New York, New York
This trial is for a treatment that removes a molecule produced by most cells in the body from HD patients' blood to help prevent a serious complication. It has been used since 1996 in Japan to improve daily living and reduce joint pain.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.